Hydrazine hydrate (1:1) → 4-Amino-1-(4-(2,3-dimethylphenyl)piperazin-1-yl)butan-2-ol
Reaktionsgleichung
[CH3:1][C:2]1[C:7]([CH3:8])=[CH:6][CH:5]=[CH:4][C:3]=1[N:9]1[CH2:14][CH2:13][N:12]([CH2:15][CH:16]([OH:30])[CH2:17][CH2:18][N:19]2C(=O)C3C(=CC=CC=3)C2=O)[CH2:11][CH2:10]1.O.NN>C(O)C>[NH2:19][CH2:18][CH2:17][CH:16]([OH:30])[CH2:15][N:12]1[CH2:11][CH2:10][N:9]([C:3]2[CH:4]=[CH:5][CH:6]=[C:7]([CH3:8])[C:2]=2[CH3:1])[CH2:14][CH2:13]1Komponenten
Versuchsvorschrift
To a mixture of 2-(4-(4-(2,3-dimethylphenyl)piperazin-1-yl)-3-hydroxybutyl)isoindoline-1,3-dione obtained in step 4 (0.26 g, 0.65 mmol) in ethanol (1.5 ml), was added hydrazine monohydrate (0.063 ml, 2.02 mmol) at room temperature. The resulting reaction mixture was stirred at room temperature for 17 hours. After the reaction complete, the reaction mixture thus obtained was sonicated and filtered. The filtrate was concentrated under reduced pressure. The residue was extracted with ethyl acetate and water. The organic phase thus separated was dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure to obtain the title compound (0.1 g). The compound was used for the next step without further purification.
Aufarbeitung
- customThe resulting reaction mixture
- customAfter the reaction complete, the reaction mixture thus obtained
- customwas sonicated
- filtrationfiltered
- concentrationThe filtrate was concentrated under reduced pressure
- extractionThe residue was extracted with ethyl acetate and water
- customThe organic phase thus separated
- dry with materialwas dried over anhydrous magnesium sulfate
- filtrationfiltered
- concentrationconcentrated under reduced pressure
Quellen und Nachweise
- ORD-Eintrag
- ord-0efbef5b40cc4dc69485ff453dcd58b4
- Quelldatensatz
- uspto-grants-2014_07
- Patentnummer
- US08785453B2
Notizen zur Reaktion
Wird geladen…